Literature DB >> 2535826

Calmodulin as substrate for insulin-receptor kinase. Phosphorylation by receptors from rat skeletal muscle.

D B Sacks1, J M McDonald.   

Abstract

Calmodulin is a substrate for insulin-receptor kinase obtained from rat adipocytes and hepatocytes and human placenta. In this study, we demonstrate that insulin stimulates the phosphorylation of calmodulin via insulin receptors partially purified from rat skeletal muscle. Phosphorylation of calmodulin was maximal in the presence of Mg2+ and insulin and the absence of Ca2+. Free-Ca2+ concentrations greater than 0.1 microM progressively inhibited phosphorylation with almost total inhibition at 200 microM Ca2+. Insulin-stimulated phosphorylation of calmodulin was dose dependent and saturable with half-maximal effect obtained at approximately 5 x 10(-10) M insulin. There was an absolute requirement for certain basic proteins, e.g., polylysine or protamine sulfate, to obtain phosphate incorporation into calmodulin. Polylysine stimulated the phosphorylation of calmodulin independently of insulin, but this was increased up to sixfold by the addition of insulin. Phosphate incorporation into calmodulin increased with increasing concentration of the substrate up to a saturating concentration of 2.4 microM. The Km for calmodulin was approximately 0.2 microM. Up to 0.15 mol of phosphate was incorporated per mole of calmodulin with tyrosine the predominant amino acid phosphorylated. The observations that calmodulin is phosphorylated by insulin-receptor kinase from all three classic target organs for insulin confirm that calmodulin is a general substrate for this kinase and suggest that Ca2+ and calmodulin may be components of the insulin-signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535826     DOI: 10.2337/diab.38.1.84

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Calmodulin and PI3K Signaling in KRAS Cancers.

Authors:  Ruth Nussinov; Guanqiao Wang; Chung-Jung Tsai; Hyunbum Jang; Shaoyong Lu; Avik Banerjee; Jian Zhang; Vadim Gaponenko
Journal:  Trends Cancer       Date:  2017-02-18

2.  Insulin receptor function is inhibited by guanosine 5'-[gamma-thio]triphosphate (GTP[S]).

Authors:  H W Davis; J M McDonald
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine).

Authors:  Y Fujita-Yamaguchi; D B Sacks; J M McDonald; D Sahal; S Kathuria
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

4.  Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.

Authors:  M K Saville; M D Houslay
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

5.  Phosphorylation by casein kinase II alters the biological activity of calmodulin.

Authors:  D B Sacks; H W Davis; J P Williams; E L Sheehan; J G Garcia; J M McDonald
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

6.  Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta.

Authors:  D B Sacks; Y Fujita-Yamaguchi; R D Gale; J M McDonald
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

7.  The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation.

Authors:  D B Sacks; B Mazus; J L Joyal
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

Review 8.  Inputs and outputs of insulin receptor.

Authors:  Yipeng Du; Taotao Wei
Journal:  Protein Cell       Date:  2014-03-16       Impact factor: 14.870

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.